NCT03980041 2022-11-25Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)Infinity Pharmaceuticals, Inc.Phase 2 Completed49 enrolled